-
Cell and Gene Therapy Manufacturing: Operational Challenges and Strategic Considerations
Neeta Ratanghayra
December 20, 2024
Producing CGTs requires highly specialized infrastructure, precise processes, and significant investments, making the manufacturing landscape both complex and costly.
-
Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing
Biotech Newswire
July 24, 2024
Touchlight announced a license agreement with GSK, a global leader in biopharmaceutical innovation.
-
Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA
PharmaSources
May 17, 2024
The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.
-
Making drug manufacturing carbon neutral throughout the supply chain
Suzanne Elvidge
March 04, 2024
In 2015, at the United Nations Climate Change Conference (COP21), 196 countries adopted the Paris Agreement to limit global warming to no more than 1.5 °C.
-
Continuous Manufacturing Part 3: Continuous Manufacturing in China
Deepak Hegde
February 05, 2024
This article, which is Part 3 and the concluding part of the series on continuous manufacturing focuses on CM in China and adoption of CM for biologic products.
-
Continuous Manufacturing Part 2: Challenges Open to CM
Deepak Hegde
February 05, 2024
This article, which is Part 2 of the series on continuous manufacturing focuses on the challenges still open to CM after the publication of ICH Q13 Guidance document and how CM could contribute to in-shoring back to US.
-
Continuous Manufacturing Part 1: Changes in Global Regulatory Landscape
Deepak Hegde
February 05, 2024
It's been about three years since I had written the three-part series of articles on Continuous Manufacturing (CM). Since then, a lot of water has flown under the bridge and there have been several developments in the field of CM. Now is probably the righ
-
Africa Vaccine Manufacturing Plans Receive Major Boost
SHEM OIRERE
January 19, 2024
Africa’s plan to manufacture at least 60% of its own vaccines to reduce dependence on imports has received a major boost after a financing initiative was launched to support investment in expanded vaccine production and supply within continent.
-
Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization
B3C newswire
January 15, 2024
January 08, 2024 ,Pluri Inc.announced it has launched a new business division offering cell therapymanufacturing services as a Contract Development and Manufacturing Organization (CDMO): PluriCDMO™.
-
Quality by design (QbD) in bio manufacturing
Shruti Talashi
December 01, 2023
Quality by design is the standard approach used for demonstrating and achieving consistent, high quality product. Rather than relying on just the post production testing, QbD practice rather encourages to improve quality at every stage of the process.